Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 32
Phase 44

Trial Status

Completed4
Other3

Role Distribution

Principal Investigator2
Other Roles5
PI Rate29%

Activity Timeline

Clinical Trials (7)

NCT00272584Phase 4Completed
CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia
Psychosis, Schizophrenia
Principalinvestigator
NCT00702793Phase 4Withdrawn
Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)
PsychosisSchizoaffectiveSchizophrenia
Studydirector
NCT00713804Phase 3Completed
Impact of Genetic Counseling for Individuals With Mental Illness
Bipolar DisorderSchizoaffective DisorderSchizophrenia
Studydirector
NCT00714818Phase 3Completed
Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness
Bipolar DisorderSchizoaffective DisorderSchizophrenia
Studydirector
NCT02213887Phase 4Withdrawn
Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
Gastroesophageal RefluxPsychotic Disorders
Studydirector
NCT02286206Phase 4Withdrawn
Study of the Effect of Dosing on Clozapine Levels
Psychotic DisordersSchizophrenia
Studydirector

Research Network

Collaboration Network

11 collaborators·27 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Alasdair Barr, Ph.D

University of British Columbia

Similar
3 trials

Shared therapeutic areas:

Psychotic DisordersSchizophreniaGastroesophageal Reflux+1 more

Worked with same sponsors:

Provincial Health Services Authority British ColumbiaUniversity of British Columbia
Collaborated on 3 trials
Similarity Score52%

Ric M. Procyshyn, Ph.D

University of British Columbia

Similar
3 trials

Shared therapeutic areas:

Psychotic DisordersSchizophreniaGastroesophageal Reflux+1 more

Worked with same sponsors:

Provincial Health Services Authority British ColumbiaUniversity of British Columbia
Collaborated on 3 trials
Similarity Score52%

Randall White, MD

University of British Columbia

Moderately Similar
2 trials

Shared therapeutic areas:

Psychotic DisordersGastroesophageal RefluxSchizophrenia

Worked with same sponsors:

University of British Columbia
Collaborated on 2 trials
Similarity Score38%

Erin Michalak

University of British Columbia

Moderately Similar
2 trials

Shared therapeutic areas:

Bipolar DisorderSchizoaffective DisorderSchizophrenia

Worked with same sponsors:

University of British Columbia
Collaborated on 2 trials
Similarity Score38%

Jehannine Austin, PhD, CCGC, CGC

University of British Columbia

Moderately Similar
2 trials

Shared therapeutic areas:

Bipolar DisorderSchizoaffective DisorderSchizophrenia

Worked with same sponsors:

University of British Columbia
Collaborated on 2 trials
Similarity Score38%

Sean Flynn, MD

University of British Columbia

Moderately Similar
1 trials

Shared therapeutic areas:

Psychotic DisordersSchizoaffectiveSchizophrenia

Worked with same sponsors:

Provincial Health Services Authority British ColumbiaUniversity of British Columbia
Collaborated on 1 trial
Similarity Score34%

Catriona Hippman

University of British Columbia

Moderately Similar
1 trials

Shared therapeutic areas:

Bipolar DisorderSchizoaffective DisorderSchizophrenia

Worked with same sponsors:

University of British Columbia
Collaborated on 1 trial
Similarity Score34%

Chris Schenk, MD

Riverview Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Psychotic DisordersSchizoaffectiveSchizophrenia

Worked with same sponsors:

Provincial Health Services Authority British ColumbiaUniversity of British Columbia
Collaborated on 1 trial
Similarity Score34%

Catriona Hippman, MSc

University of British Columbia

Moderately Similar
1 trials

Shared therapeutic areas:

Bipolar DisorderSchizoaffective DisorderSchizophrenia

Worked with same sponsors:

University of British Columbia
Collaborated on 1 trial
Similarity Score34%

Joyce Coutts, MD

Forensic Psychiatric Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Psychotic DisordersSchizoaffectiveSchizophrenia

Worked with same sponsors:

Provincial Health Services Authority British ColumbiaUniversity of British Columbia
Collaborated on 1 trial
Similarity Score34%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT00175513Phase 2PrincipalInvestigator

V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis

Psychosis
Completed
NCT00272584Phase 4PrincipalInvestigator

CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia

Psychosis, Schizophrenia
Completed
NCT00702793Phase 4StudyDirector

Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)

PsychosisSchizoaffectiveSchizophrenia
Withdrawn
NCT00713804Phase 3StudyDirector

Impact of Genetic Counseling for Individuals With Mental Illness

Bipolar DisorderSchizoaffective DisorderSchizophrenia
Completed
NCT00714818Phase 3StudyDirector

Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness

Bipolar DisorderSchizoaffective DisorderSchizophrenia
Completed
NCT02213887Phase 4StudyDirector

Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications

Gastroesophageal RefluxPsychotic Disorders
Withdrawn
NCT02286206Phase 4StudyDirector

Study of the Effect of Dosing on Clozapine Levels

Psychotic DisordersSchizophrenia
Withdrawn

All 7 trials loaded